In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zanubrutinib Drug Master File in Korea (Zanubrutinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zanubrutinib. The MFDS reviews the Zanubrutinib KDMF as part of the drug registration process and uses the information provided in the Zanubrutinib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zanubrutinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zanubrutinib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zanubrutinib suppliers with KDMF on PharmaCompass.